Kamada Ltd (KMDA) - Financial and Strategic SWOT Analysis Review

  • ID: 4285040
  • SWOT Analysis
  • 51 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • CSL Behring
  • Emergent BioSolutions Inc
  • Grifols SA
  • RedHill Biopharma Ltd
  • Shire
  • MORE
Amanda Ltd (KMDA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Amanda Ltd (Amanda) is a biopharmaceutical company that develops, manufactures and markets specialty proteins, specific immunoglobulin's and other prescription medicines. Its major products include pulmonary related medicines, immunologist, vaccines and critical care medicines. It also offers medicines for the treatment of cystic fibrosis, asthma, hemophilia, rabies, hepatitis B, and other indications. Amanda's pipeline products include intravenous and inhaled AAT protein and rabies. Its intravenous formulations are intended for Graft vs Host Disease (GVHD), type-1 diabetes and lung transplantation indications. The company distributes its products through a network of distributors in Brazil, Israel, Russia, India and other countries in Eastern Europe, Latin America and Asia regions. Amanda is headquartered in Ness Zion, Israel.

Amanda Ltd Key Recent Developments

Aug 16, 2018: Amanda announces the end of the labor strike in the company’s manufacturing facility; all employees returned to work
Aug 07, 2018: Amanda announces financial results for second quarter and first six months of 2018
May 15, 2018: Amanda Reports Financial Results for First Quarter of 2018
Feb 07, 2018: Amanda Reports Financial Results for Fourth Quarter and Full-Year 2017
Nov 13, 2017: Amanda Reports Financial Results for Third Quarter and First Nine Months of 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • CSL Behring
  • Emergent BioSolutions Inc
  • Grifols SA
  • RedHill Biopharma Ltd
  • Shire
  • MORE
Section 1 - About the Company
Kamada Ltd - Key Facts
Kamada Ltd - Key Employees
Kamada Ltd - Key Employee Biographies
Kamada Ltd - Major Products and Services
Kamada Ltd - History
Kamada Ltd - Company Statement
Kamada Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis
Company Overview
Kamada Ltd - Business Description
Business Segment: Distribution Segment
Overview
Performance
Business Segment: Proprietary Products Segment
Overview
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Israel
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: Others
Performance
Geographical Segment: The US
Performance
R&D Overview
Kamada Ltd - SWOT Analysis
SWOT Analysis - Overview
Kamada Ltd - Strengths
Kamada Ltd - Weaknesses
Kamada Ltd - Opportunities
Kamada Ltd - Threats
Kamada Ltd - Key Competitors

Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances
Kamada Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Kamada Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Kamada Ltd, Recent Deals Summary

Section 5 – Company’s Recent Developments
Aug 16, 2018: Kamada announces the end of the labor strike in the company’s manufacturing facility; all employees returned to work
May 15, 2018: Kamada Reports Financial Results for First Quarter of 2018
Feb 07, 2018: Kamada Reports Financial Results for Fourth Quarter and Full-Year 2017
Nov 13, 2017: Kamada Reports Financial Results for Third Quarter and First Nine Months of 2017
Nov 10, 2017: Kamada Announces Nomination of Three New Members to its Board of Directors
Nov 10, 2017: Kamada Announces Nomination of Three New Members to its Board of Directors
Sep 18, 2017: Kamada Announces CFO Transition
Sep 06, 2017: Kamada Announces Collaboration with BGN Technologies for Advanced Alpha-1 Antitrypsin Research with a Focus on Mechanism of Action
Aug 01, 2017: Kamada Reports Financial Results for Second Quarter and First Six Months of 2017
Jul 27, 2017: Kamada Pre-Announces Certain Preliminary Financial Results for Second Quarter and First Six Months of 2017

Section 6 – Appendix
Methodology
Ratio Definitions
About
Contact Us
Disclaimer

List of Tables
Kamada Ltd, Key Facts
Kamada Ltd, Key Employees
Kamada Ltd, Key Employee Biographies
Kamada Ltd, Major Products and Services
Kamada Ltd, History
Kamada Ltd, Other Locations
Kamada Ltd, Subsidiaries
Kamada Ltd, Key Competitors
Kamada Ltd, Ratios based on current share price
Kamada Ltd, Annual Ratios
Kamada Ltd, Interim Ratios
Kamada Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Kamada Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Kamada Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Kamada Ltd, Performance Chart (2013 - 2017)
Kamada Ltd, Ratio Charts
Kamada Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Kamada Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Shire
  • RedHill Biopharma Ltd
  • Grifols SA
  • Emergent BioSolutions Inc
  • CSL Behring
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll